← Leaderboards
Chris None Baylis
West Virginia University
$7,483,914
Attributed
$7,584,953
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $827.9K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,584,953 · 5
By mechanism
R01$5,596,765 · 3
T32$1,786,110 · 1
R21$202,078 · 1
Top collaborators
- Peter P Sayeski1 shared
Others in their field
Top investigators on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Paula Darby Lipman · Westat, Inc.$52,914,492
- Walter N Kernan · Yale University$42,197,025
- Rohit Varma · University Of Southern California$35,266,606
- Susan S Redline · Brigham And Women'S Hospital$35,248,244
- Marlene Rabinovitch · Stanford University$34,807,202
Research focus
HypertensionNitric OxideNitric Oxide SynthaseArginineProtein IsoformsEnzyme ActivityProteinsChronicLocationKidneyLaboratory RatHemodynamicsIn VivoRattusKidney FunctionIn VitroEnzymesLaboratory MouseDosePlayEnzyme InhibitorsInhibitor/AntagonistInjuryAnimals
Grant awards (29)
Nitric oxide deficiency in chronic renal disease$326,250
R01 · FY2015 · DK · contact PI
Nitric oxide deficiency in chronic renal disease$326,250
R01 · FY2014 · DK · contact PI
Multidisciplinary Training Program in Hypertension$314,949
T32 · FY2014 · HL · contact PI
Nitric oxide deficiency in chronic renal disease$313,083
R01 · FY2013 · DK · contact PI
Multidisciplinary Training Program in Hypertension$230,264
T32 · FY2013 · HL · contact PI
Nitric oxide deficiency in chronic renal disease$324,075
R01 · FY2012 · DK · contact PI
Vascular ANGII/Jak2 in progression of renal disease$202,078
R21 · FY2012 · DK · contact PI
Multidisciplinary Training Program in Hypertension$201,503
T32 · FY2011 · HL · contact PI
Multidisciplinary Training Program in Hypertension$289,067
T32 · FY2010 · HL · contact PI
Nitrix Oxide in Chronic Renal Disease$287,947
R01 · FY2010 · DK · contact PI
Nitrix Oxide in Chronic Renal Disease$291,307
R01 · FY2009 · DK · contact PI
Multidisciplinary Training Program in Hypertension$286,915
T32 · FY2009 · HL · contact PI
Nitrix Oxide in Chronic Renal Disease$291,700
R01 · FY2008 · DK · contact PI
Multidisciplinary Training Program in Hypertension$282,690
T32 · FY2008 · HL · contact PI
IMCD phosphodiesterase in pregnancy; role in ECFVE$253,536
R01 · FY2008 · HD · contact PI
Nitrix Oxide in Chronic Renal Disease$298,002
R01 · FY2007 · DK · contact PI
IMCD phosphodiesterase in pregnancy; role in ECFVE$258,710
R01 · FY2007 · HD · contact PI
Multidisciplinary Training Program in Hypertension$180,722
T32 · FY2007 · HL · contact PI
IMCD phosphodiesterase in pregnancy; role in ECFVE$266,437
R01 · FY2006 · HD · contact PI
IMCD phosphodiesterase in pregnancy;role in ECFVE$272,848
R01 · FY2005 · HD
IMCD phosphodiesterase in pregnancy;role in ECFVE$278,335
R01 · FY2004 · HD
Nitric Oxide in Chronic Renal Disease$229,163
R01 · FY2004 · DK
Nitric Oxide in Chronic Renal Disease$229,950
R01 · FY2003 · DK
NITRIC OXIDE 'NO'AND THE KIDNEY$224,840
R01 · FY2003 · DK
Nitric Oxide in Chronic Renal Disease$229,950
R01 · FY2002 · DK
NITRIC OXIDE 'NO'AND THE KIDNEY$224,840
R01 · FY2002 · DK
Nitric Oxide in Chronic Renal Disease$226,644
R01 · FY2001 · DK
NITRIC OXIDE 'NO'AND THE KIDNEY$224,840
R01 · FY2001 · DK
NITRIC OXIDE 'NO'AND THE KIDNEY$218,058
R01 · FY2000 · DK